Over the last few years, with fears increased in the healthcare industry that its top executives could be targets of violence ...

The S&P 500 and Nasdaq lost ground at midday as the Trump administration's reciprocal tariffs are set to kick in this week.

Kate Cronin, who took the marketing reins at Moderna in 2021 as it was skyrocketing to global renown for its COVID-19 vaccine, is stepping down from her post. Cronin joined Moderna in the summer ...

The S&P 500 gained 0.6% on Monday, March 31, boosted by an afternoon rally even as investors brace for the planned onset of ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Tom Yeung here with your Sunday Digest.  Last week, I revealed five ...

The U.S. government continues to end contracts related to the $5 billion Project NextGen initiative, this time terminating ...

"Strengthening and supporting our global health workforce is essential to building resilient systems capable of responding to current and future health crises," he said. Bipartisan support reinforces ...

Claim construction hearing for Pfizer/BioNTech mRNA-LNP vaccine litigation occurred in December 2024; outcome pending Jury trial in Moderna U.S.

The company has said it doesn’t need to raise new cash, and Moderna CEO Stephane Bancel has said he would keep cutting costs if sales fall short. There’s likely more room to slash: Moderna ...

Fresh sales data on Tuesday showed continued poor performance for electric vehicle maker Tesla (TSLA) in Europe, amid backlash against CEO Elon Musk's political ... pre-market trading on Tuesday.

The Aurora Humanitarian Initiative and the Promise Institute for Human Rights at UCLA Law announced Monday the lineup of ...

Experts expect the NIH funding freeze to reduce new drug development and impede scientists' growth across American research facilities.